CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ)
$1.99 -0.07 (-3.3981%)
Analysed CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) News Sources
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
30-03-2026
yahoo.com
Connect Biopharma Announces $20.2 Million Private Placement Financing
30-03-2026
yahoo.com
Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses
30-03-2026
marketbeat.com
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
31-03-2026
yahoo.com
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
07-04-2026
yahoo.com
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
23-04-2026
yahoo.com
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
12-05-2026
yahoo.com
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Could Be Quite Risky
15-05-2026
yahoo.com
Connect Biopharma Touts Rademikibart’s Edge as SEABREEZE Data Looms in 2026
22-05-2026
marketbeat.com
What is the current price of CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ)?
The current price of CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) is $1.99.
CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) absolute price change since previous trading day?
The absolute price change of CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) since the previous trading day is $-0.07.
CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) percentage price change since previous trading day?
The percentage price change of CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) since the previous trading day is -3.3981%.
What is the most recent average sentiment score for CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ)?
The most recent average sentiment score for CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ)?
The most recent sentiment for CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ) is .
SEC-8K** Filing Available For CONNECT BIOPHARMA HOLDINGS L (CNTB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.